Tropisetron
Prescription anti-nausea drug also researched as a nootropic and neuroprotectant; that use is still experimental.
Pharmacology
Contents
DETAILED OVERVIEW
What is Tropisetron?
Tropisetron is a prescription anti-nausea medicine (Navoban), approved for nausea caused by chemotherapy and surgery in several EU member states and other countries; it has not been approved in the USA. Its use as a nootropic, that is, as a substance supporting brain performance, is experimental and off-label.
Its anti-nausea effect is based on blocking a nausea-triggering serotonin signal. It also partially activates a nicotine-sensitive receptor (a signal-receiving protein) in the brain that plays a role in memory, filtering of sensory input and calming inflammation. In a short human study in schizophrenia it improved the filtering of auditory stimuli and some thinking problems. In animal studies it showed neuroprotective and anti-inflammatory effects. Its most common side effect is headache; it can lengthen the QT interval, that is, cause a change in heart rhythm. It is contraindicated in congenital long QT syndrome, and its safety in pregnancy and breastfeeding has not been shown.
Mechanism
5-HT3 antagonist + α7 nicotinic partial agonist
Half-life
~6-8 h (longer in poor metabolizers)
Legal status
Rx antiemetic (EU; not FDA-approved)
No anecdote collected yet.
Receptor profile
- Alpha-7 nicotinic acetylcholine receptor (α7 nAChR)Strong
- Serotonin 5-HT3 receptor (antagonist)Strong
- Beta-amyloid (experimental neuroprotection)Moderate
- Dopamine (dose-dependent)Weak
Safety
Side effects, stop signs, contraindications
Side effects · 5
- Headache, the most common antiemetic side effect
- Constipation and digestive discomfort
- Dizziness, drowsiness or fatigue
- QT prolongation and heart-rhythm changes, especially at high doses or with other QT-prolonging drugs
- Rarely abdominal pain, diarrhea or transient blood-pressure changes
Contraindications · 5
- Pregnancy and breastfeeding: safety not adequately established, avoid
- Congenital long QT syndrome, arrhythmia or concurrent use of other QT-prolonging drugs
- Known hypersensitivity to tropisetron or other 5-HT3 antagonists
- Poor CYP2D6 metabolizers: elevated plasma levels and prolonged exposure
- Prescription medicine, not recommended as a nootropic without medical supervision
Related Nootropics
Same therapeutic category
Studies
Related research and clinical findings
Short-term tropisetron treatment and cognitive and P50 auditory gating deficits in schizophrenia
A placebo-controlled study of tropisetron added to risperidone for the treatment of negative symptoms in chronic and stable schizophrenia
Tropisetron enhances recognition memory in rats chronically treated with risperidone or quetiapine
Activation of alpha-7 nicotinic acetylcholine receptor by tropisetron mitigates 3-nitropropionic acid-induced Huntington's disease in rats
Tropisetron attenuates neuroinflammation and chronic neuropathic pain via α7nAChR activation in the spinal cord in rats
Involvement of stimulation of α7 nicotinic acetylcholine receptors in the suppressive effect of tropisetron on dextran sulfate sodium-induced colitis in mice
FAQ
FAQ
Tropisetron is a prescription antiemetic medicine, approved mainly to prevent nausea from chemotherapy and surgery. Researchers have also looked at its effects on the brain: short human studies found it improved certain attention-related cognitive measures in schizophrenia, and animal studies showed anti-inflammatory, nerve-protective and pain-reducing effects, but those cognitive and brain-protective uses are still experimental.
Telegram
Have a question about Tropisetron?
Reach out to us on Telegram for a personalized stack. We'll be happy to help.
Personalized consultation
Want a detailed conversation tailored to your data?
Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.
Fill out the form~5–7 min · prep questionnaire · confidential · GDPR-compliant
Structure & chemistry
The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.